Calumet, Inc.
CLMTBasic MaterialsNASDAQSpecialty Chemicals · Last scanned Sep 7, 2026
Scan Results
Daily timeframeCalumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. The $4.67B market capitalization puts CLMT squarely in mid-cap range for its industry. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments.
Market Cap
$4.67B
Beta
0.72
P/E (TTM)
—
P/E (Fwd)
84.33
EPS (TTM)
$-1.54
EPS (Fwd)
$0.63
ROE
—
ROA
-1.3%
Cash
$109.8M
Total Debt
$2.37B
Free CF
$172.6M
52W Change
199.0%
Annual Financials
Cash vs Debt
Where CLMT stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CLMT finished 51.11% above its 150-day moving average ($35.12) and 69.55% above its 200-day moving average ($31.30). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CLMT overbought or oversold?
At the September 3, 2026 close, CLMT's RSI(14) was 61.0, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, CLMT has $109.8M in cash with $2.37B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $172.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Revenue has pulled back from $4.69B (2022) to $4.14B (2025), a 12% decline worth watching.
Calumet, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CLMT.